SUTENT 12,5 mg, gélule — 28 plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC de 1 gélule(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400938210224 -
CIP7
3821022 -
CIS
69225978 -
Registration number
EU/1/06/347
What the source publishes
- Holder
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Active ingredients
- SUNITINIB, MALATE DE SUNITINIB
- Form
- gélule
- Package
- 28 plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC de 1 gélule(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2006-07-19
- Prescription
- Prescription or restricted
Names this record is found by
- SUTENT 12,5 mg, gélule — 28 plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC de 1 gélule(s)
- SUTENT 12,5 mg, gélule
- SUNITINIB
- MALATE DE SUNITINIB
Complete source data
{
"cis": "69225978",
"cip7": "3821022",
"form": "gélule",
"name": "SUTENT 12,5 mg, gélule — 28 plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC de 1 gélule(s)",
"cip13": "3400938210224",
"holder": "PFIZER EUROPE MA EEIG (BELGIQUE)",
"routes": [
"orale"
],
"holders": [
"PFIZER EUROPE MA EEIG (BELGIQUE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "478.84",
"authorisedOn": "2006-07-19",
"compositions": [
{
"name": "SUNITINIB",
"nature": "FT",
"strength": "12,5 mg",
"linkageNumber": "1",
"substanceCode": "29335",
"dosageReference": "une gélule",
"pharmaceuticalElement": "gélule"
},
{
"name": "MALATE DE SUNITINIB",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "41239",
"dosageReference": null,
"pharmaceuticalElement": "gélule"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": "1.02",
"medicinePrice": "477.82",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "SUTENT 12,5 mg, gélule",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "28 plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC de 1 gélule(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100%"
],
"marketingDeclaredOn": "2008-10-21",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"SUNITINIB",
"MALATE DE SUNITINIB"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
"prescription réservée aux spécialistes et services HEMATOLOGIE",
"prescription hospitalière",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/06/347",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400938210224"